Biomechanical Precision Medicine Registry for Patients With and Without Heart Failure
Part of paid clinical trials in Boston, Massachusetts.
- Sponsor
- Massachusetts General Hospital
- Study ID
- NCT03480633
- Status
- Recruiting
Conditions
- Cardiovascular Risk Factor
- Heart Failure With Mid Range Ejection Fraction
- Heart Failure With Normal Ejection Fraction
- Heart Failure With Reduced Ejection Fraction
- Heart Failure, Right Sided
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Study Details
In this single-center, longitudinal observational study, we will comprehensively examine clinical characteristics, proteomic, metabolomic, genomic and imaging data to better understand how different heart failure types may develop and progress over time. We will evaluate distinct sub-groups of heart failure (also known as heart failure phenotypes) and cardiomyopathies including amyloidosis with an ultimate goal of bringing the right medications and therapy to the right patients to optimize benefit and minimized side effects, an effort to improve precision medicine in heart failure.
Key Dates
- Start date
- Apr 7, 2016
- Status verified
- Dec 2025
- Primary completion
- Apr 6, 2026
- Completion
- Oct 6, 2027
Study Design
- Enrollment
- 3,000 participants (estimated)
Arms
- Arm: ControlDefined as patients without a history of heart failure
- Arm: Heart Failure w/NormalEjectionFractionHeart Failure with Normal Ejection Fraction is defined as having a Left Ventricle Ejection Fraction of greater than or equal to 50%.
- Arm: HeartFailure w/ReducedEjectionFractionHeart Failure with Reduced Ejection Fraction is defined as having a Left Ventricle Ejection Fraction of less than 50%.
Primary Outcome Measure
Major adverse cardiovascular events (MACE) [ Time Frame: Time from sample collection until the date of documented event up to 60 months after the study closure. ]
Central Contacts
- Abbie Macher, BS617-643-6328
- Laura Stockhausen, BS617-724-1339
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | Heather Jameson, PhD Hanna Gaggin, MD, MPH (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Boston, MA
Related Studies
- Imaging Histone Deacetylase in the HeartRecruiting · Massachusetts General Hospital · Boston, Massachusetts
- Assessment of CCM in HF With Higher Ejection FractionRecruiting · Impulse Dynamics · Birmingham, Alabama
- Left vs Left Randomized Clinical TrialRecruiting · Baylor College of Medicine · Gilbert, Arizona
- Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection FractionPHASE3 · Recruiting · Cytokinetics · Alexander City, Alabama